Drug results: 1
teprotumumab | Teprotumumab-trbw’s mechanism of action in patients with Thyroid Eye Disease has not been fully characterized. Teprotumumab-trbw binds to IGF-1R and blocks its activation and signaling |
Citing DrugCentral © 2024. License